NASDAQ$BTTC

Black Titan Corp · Q3 2017 earnings

Q3 2017 earnings · Reported Nov 9, 2017 (9 years ago) · Investor relations

Nov 9Sep 30, 2017

Total Revenue

$40K

Previous: $26K+53.8%

EPS (adj)

-$720.00

Previous: -$432.00-66.7%

Capital Expenditures

$129K

Previous: $48K+168.8%

Free Cash Flow

-$3.67M

Previous: $8.65M-142.5%

Net Income

-$4.19M

Previous: -$2.62M-60.0%

Operating Income

-$4.07M

Previous: -$2.62M-55.6%

Gross Profit

-$2.67M

Previous: -$1.56M-71.0%

Cash & Equivalents

$11.7M

Previous: $16.5M-29.1%

Total Assets

$12.7M

Previous: $23.5M-45.9%

Stock-Based Comp

$404K

Previous: $202K+100.0%

Titan Pharmaceuticals · Revenue · Quarterly

$40K

Q3 2017+53.8%vs Q3 2016

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation